𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

✍ Scribed by Haiyung Cheng; Jonathan A. Leff; Raju Amin; Barry J. Gertz; Marina De Smet; Nancy Noonan; J. Douglas Rogers; William Malbecq; Dale Meisner; G. Somers

Book ID
110344814
Publisher
Springer US
Year
1996
Tongue
English
Weight
675 KB
Volume
13
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics and bioavailability of
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers
✍ Jamie J. Zhao; J. Douglas Rogers; Sherry D. Holland; Patrick Larson; Raju D. Ami πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 1 views

A study was conducted to (i) characterize the multiple-dose pharmacokinetics of oral montelukast sodium (MK-0476), 10 mg d 71 in healthy young subjects (N 12), (ii) evaluate the pharmacokinetics of montelukast in healthy elderly subjects (N 12), and (iii) compare the pharmacokinetics and oral bioava

PHARMACOKINETICS AND FOOD INTERACTION OF
PHARMACOKINETICS AND FOOD INTERACTION OF MK-462 IN HEALTHY MALES
✍ Haiyung Cheng; William J. Polvino; David Sciberras; L. Yogendran; Kristine A. Ce πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 429 KB πŸ‘ 2 views

A study was conducted to assess the safety, tolerability, and pharmacokinetics of single intravenous (IV) doses of 5-90pgkg-' of MK-462, and the effect of food on the pharmacokinetics of MK-462 administered orally to healthy males. Results of this study indicate that IV doses of MK-462 from 5 to 90p

PHARMACOKINETICS AND ABSOLUTE BIOAVAILAB
PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF EPRISTERIDE IN HEALTHY MALE SUBJECTS
✍ Lisa Jo Benincosa; Patricia R. Audet; Dave Lundberg; NΓ©vine Zariffa; Diane K. Jo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

The objective of the current investigation was to describe the pharmacokinetics and absolute oral bioavailability of epristeride. Twelve healthy male subjects (mean (SD) age, 27 (6.2) years) received a single oral dose of 5mg and an intravenous infusion of 4.5 mg over 30 min in a crossover fashion.